Cover Image
市場調查報告書

皮膚肌炎:開發中產品分析

Dermatomyositis - Pipeline Review, H1 2018

出版商 Global Markets Direct 商品編碼 361637
出版日期 內容資訊 英文 201 Pages
訂單完成後即時交付
價格
Back to Top
皮膚肌炎:開發中產品分析 Dermatomyositis - Pipeline Review, H1 2018
出版日期: 2018年05月16日 內容資訊: 英文 201 Pages
簡介

皮膚肌炎是一種罕見的炎症性疾病,其特徵在於伴有肌肉無力的慢性肌肉發炎。皮肌炎的症狀包括獨特的皮疹,肌肉無力和發炎性肌病,或引起肌肉發炎。危險因素包括年齡和性別。治療可採用皮質類固醇。

本報告提供皮膚肌炎治療藥的開發情形相關調查,提供開發中產品概要,各臨床實驗階段的產品概要,主要企業及藥物簡介,開發中產品的最新趨勢,及最新消息/新聞稿等資訊。

簡介

  • 調查範圍

皮膚肌炎概要

治療藥的開發

  • 開發中產品的概要
  • 各企業的開發平台
  • 企業開發中的產品

皮膚肌炎:治療藥的評估

  • 標的別
  • 各作用機制
  • 各給藥途徑
  • 各分子類型

開發皮膚肌炎治療藥的企業

  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Hope Pharmaceuticals Inc
  • Idera Pharmaceuticals Inc
  • KPI Therapeutics Inc
  • Marathon Pharmaceuticals LLC
  • MedImmune LLC
  • Neovacs SA
  • Novartis AG
  • Octapharma AG
  • Pfizer Inc

藥物簡介

皮膚肌炎:暫停中的計劃

皮膚肌炎:產品開發的里程碑

  • 主要消息和新聞稿

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC10437IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline landscape.

Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 6, 9, 6, 5, 13, 8 and 2 respectively.

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders).
  • The pipeline guide reviews pipeline therapeutics for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders)

Reasons to buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Table of Contents
  • Introduction
  • Ankylosing Spondylitis (Bekhterev's Disease) - Overview
  • Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Development
  • Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Assessment
  • Ankylosing Spondylitis (Bekhterev's Disease) - Companies Involved in Therapeutics Development
  • Ankylosing Spondylitis (Bekhterev's Disease) - Drug Profiles
  • Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects
  • Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products
  • Ankylosing Spondylitis (Bekhterev's Disease) - Product Development Milestones
  • Appendix

List of Tables

  • Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2018
  • Number of Products under Development by Companies, H1 2018
  • Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
  • Products under Development by Companies, H1 2018
  • Products under Development by Companies, H1 2018 (Contd..1), H1 2018
  • Products under Development by Companies, H1 2018 (Contd..2), H1 2018
  • Number of Products by Stage and Target, H1 2018
  • Number of Products by Stage and Mechanism of Action, H1 2018
  • Number of Products by Stage and Route of Administration, H1 2018
  • Number of Products by Stage and Molecule Type, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by AbbVie Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Adello Biologics LLC, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Alteogen Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Amgen Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocad, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocon Ltd, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Bionovis SA, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Celgene Corp, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Coherus BioSciences Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Eli Lilly and Co, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Fresenius SE & Co KGaA, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Galapagos NV, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Genor BioPharma Co Ltd, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Immunwork Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Innovent Biologics Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Izana Bioscience Ltd, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Mycenax Biotech Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Novartis AG, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Nuevolution AB, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Oncobiologics Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Pfizer Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Protalix BioTherapeutics Inc, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Reliance Life Sciences Pvt Ltd, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sandoz International GmbH, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Shanghai Pharmaceutical Co Ltd, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by UCB SA, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Xbrane Biopharma AB, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H1 2018 (Contd..1), H1 2018
  • Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products, H1 2018

List of Figures

  • Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2018
  • Number of Products under Development by Companies, H1 2018
  • Number of Products by Top 10 Targets, H1 2018
  • Number of Products by Stage and Top 10 Targets, H1 2018
  • Number of Products by Top 10 Mechanism of Actions, H1 2018
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
  • Number of Products by Routes of Administration, H1 2018
  • Number of Products by Stage and Routes of Administration, H1 2018
  • Number of Products by Molecule Types, H1 2018
  • Number of Products by Stage and Top 10 Molecule Types, H1 2018
Back to Top